Adenosine in pancreatic cancer: Emerging combination therapies.
作者信息
Roth Susanne, Hackert Thilo
机构信息
Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
出版信息
EBioMedicine. 2019 Oct;48:20-21. doi: 10.1016/j.ebiom.2019.09.030. Epub 2019 Oct 4.
Abstract
摘要
相似文献
1
Adenosine in pancreatic cancer: Emerging combination therapies.胰腺癌中的腺苷：新兴的联合疗法。
EBioMedicine. 2019 Oct;48:20-21. doi: 10.1016/j.ebiom.2019.09.030. Epub 2019 Oct 4.
2
Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).PP1和GL-2003（抗PAK1药物，酪氨酸激酶抑制剂）联合对人胰腺癌及NF1缺陷型乳腺癌小鼠异种移植瘤的信号治疗
Cancer Lett. 2007 Jan 8;245(1-2):242-51. doi: 10.1016/j.canlet.2006.01.018. Epub 2006 Mar 15.
3
Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis.通过将 Akt/p21 依赖性衰老转换为细胞凋亡来增强腺苷对胰腺癌的治疗效果。
EBioMedicine. 2019 Sep;47:114-127. doi: 10.1016/j.ebiom.2019.08.068. Epub 2019 Sep 5.
4
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.白细胞介素-6和程序性死亡受体配体1抗体阻断联合疗法可降低胰腺癌小鼠模型中的肿瘤进展。
Gut. 2018 Feb;67(2):320-332. doi: 10.1136/gutjnl-2016-311585. Epub 2016 Oct 21.
5
In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.染料木黄酮增强顺铂对胰腺癌疗效作用的体外和体内分子证据。
Int J Cancer. 2007 Feb 15;120(4):906-17. doi: 10.1002/ijc.22332.
6
Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.在BxPC-3胰腺肿瘤异种移植模型中，大豆异黄酮染料木黄酮可增强顺铂诱导的抗肿瘤活性。
Cancer. 2006 Mar 15;106(6):1260-8. doi: 10.1002/cncr.21731.
7
Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy.表皮生长因子受体与血管内皮生长因子受体-2联合靶向治疗的协同抗肿瘤作用
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2197-207. doi: 10.1158/1078-0432.CCR-05-1682.
8
Updates and controversies in the treatment of pancreatic cancer.胰腺癌治疗的进展与争议
Clin Adv Hematol Oncol. 2006 Jan;4(1):47-54.
9
Combination paclitaxel and inhibitor of nuclear factor κB activation improves therapeutic outcome for model mice with peritoneal dissemination of pancreatic cancer.联合紫杉醇和核因子-κB 激活抑制剂可改善胰腺癌腹膜扩散模型小鼠的治疗效果。
Pancreas. 2011 May;40(4):600-7. doi: 10.1097/MPA.0b013e31820b9257.
10
Grading animal distress and side effects of therapies.动物痛苦程度和治疗副作用分级。
Ann N Y Acad Sci. 2020 Aug;1473(1):20-34. doi: 10.1111/nyas.14338. Epub 2020 Mar 24.
引用本文的文献
1
Cancer biology and molecular genetics of A adenosine receptor.A 腺苷受体的癌症生物学和分子遗传学。
Oncogene. 2022 Jan;41(3):301-308. doi: 10.1038/s41388-021-02090-z. Epub 2021 Nov 8.
2
Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients.吸入式腺苷治疗住院 COVID-19 患者的疗效和效果。
Front Immunol. 2021 Mar 18;12:613070. doi: 10.3389/fimmu.2021.613070. eCollection 2021.
本文引用的文献
1
Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis.通过将 Akt/p21 依赖性衰老转换为细胞凋亡来增强腺苷对胰腺癌的治疗效果。
EBioMedicine. 2019 Sep;47:114-127. doi: 10.1016/j.ebiom.2019.08.068. Epub 2019 Sep 5.
2
Supraventricular Tachycardia: Mechanistic Insights Deduced From Adenosine.室上性心动过速：从腺苷推导得出的机制见解
Circ Arrhythm Electrophysiol. 2018 Dec;11(12):e006953. doi: 10.1161/CIRCEP.118.006953.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Targeting immunosuppressive adenosine in cancer.靶向肿瘤中的免疫抑制腺苷。
Nat Rev Cancer. 2017 Dec;17(12):709-724. doi: 10.1038/nrc.2017.86. Epub 2017 Oct 23.
5
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.比较吉西他滨和卡培他滨辅助治疗与吉西他滨单药治疗可切除胰腺癌患者的效果（ESPAC-4）：一项多中心、开放标签、随机、3 期临床试验。
Lancet. 2017 Mar 11;389(10073):1011-1024. doi: 10.1016/S0140-6736(16)32409-6. Epub 2017 Jan 25.
6
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.预计 2030 年美国癌症发病与死亡人数：甲状腺癌、肝癌和胰腺癌带来的意外负担。
Cancer Res. 2014 Jun 1;74(11):2913-21. doi: 10.1158/0008-5472.CAN-14-0155.
7
Immunity, inflammation and cancer: a leading role for adenosine.免疫、炎症与癌症：腺苷的主导作用
Nat Rev Cancer. 2013 Dec;13(12):842-57. doi: 10.1038/nrc3613. Epub 2013 Nov 14.
8
AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.AKT 通过 mTORC1 和 p53 在没有 DNA 损伤的情况下诱导人细胞衰老：在恶性肿瘤期间靶向 mTOR 的意义。
Oncogene. 2012 Apr 12;31(15):1949-62. doi: 10.1038/onc.2011.394. Epub 2011 Sep 12.
9
Nucleoside analogues and nucleobases in cancer treatment.癌症治疗中的核苷类似物和碱基
Lancet Oncol. 2002 Jul;3(7):415-24. doi: 10.1016/s1470-2045(02)00788-x.
Zotero 插件